Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab

Anna Schuch; Tatjana Fischer; Alexander Boehner; Tilo Biedermann; Thomas Volz

doi:10.2340/00015555-2794

Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab

Anna Schuch, Tatjana Fischer, Alexander Boehner, Tilo Biedermann, Thomas Volz

Medicine and Health

Technical University of Munich

Research output: Contribution to journal › Comment/debate

45 Scopus citations

Original language	English
Pages (from-to)	151-152
Number of pages	2
Journal	Acta Dermato-Venereologica
Volume	98
Issue number	1
DOIs	https://doi.org/10.2340/00015555-2794
State	Published - 2018

Access to Document

10.2340/00015555-2794

Cite this

@article{7900f890b60d49ebbf3fdd3e5b8204b3,

title = "Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab",

author = "Anna Schuch and Tatjana Fischer and Alexander Boehner and Tilo Biedermann and Thomas Volz",

year = "2018",

doi = "10.2340/00015555-2794",

language = "English",

volume = "98",

pages = "151--152",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals/Acta D-V",

number = "1",

}

TY - JOUR

T1 - Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab

AU - Schuch, Anna

AU - Fischer, Tatjana

AU - Boehner, Alexander

AU - Biedermann, Tilo

AU - Volz, Thomas

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85040411925&partnerID=8YFLogxK

U2 - 10.2340/00015555-2794

DO - 10.2340/00015555-2794

M3 - Comment/debate

C2 - 28902952

AN - SCOPUS:85040411925

SN - 0001-5555

VL - 98

SP - 151

EP - 152

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

IS - 1

ER -

Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab

Access to Document

Other files and links

Cite this